ARTICLE | Company News
Helsinn, Mundipharma deal
February 23, 2015 8:00 AM UTC
Helsinn granted Mundipharma exclusive rights to commercialize anamorelin in Brazil and “key markets” in the Middle East and North Africa. The once-daily small molecule ghrelin agonist has completed ...